Jacobs Levy Equity Management, Inc Magenta Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $87,337 - $164,225	-19,715 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $805,932 - $1.31 Million	-132,773 Reduced 87.07%	19,715 $144,000
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $19,920 - $28,880	2,041 Added 1.36%	152,488 $1.49 Million
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $344,301 - $601,404	-44,948 Reduced 23.0%	150,447 $1.78 Million
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $969,558 - $1.26 Million	158,944 Added 436.05%	195,395 $1.53 Million
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $18,758 - $25,720	-2,877 Reduced 7.32%	36,451 $248,000
Q2 2020 Aug 17, 2020	BUY	$6.18 - $10.76 $243,047 - $423,169	39,328 New	39,328 $295,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.